<DOC>
	<DOCNO>NCT00806117</DOCNO>
	<brief_summary>Cervical cancer still common gynecologic cancer . There obvious increase survival year . The risk recurrence radical surgery increase positive lymph node , positive surgical margin , positive lymphatic vascular space deep invasion cervical stroma . In recent year , role chemotherapy cervical cancer gradually recognize . But adjuvant therapy post-surgery , chemotherapy improve overall survival rate patient adverse pathological prognostic factor inconclusive . In study , order investigate effect adverse reaction chemotherapy adjuvant therapy post-surgery patient adverse pathological prognostic factor , nine hundred ninety patient randomly divide three group , compare radiotherapy alone , concurrent chemoradiation sequence chemotherapy radiotherapy ( 2 cycle chemotherapy Paclitaxel Cisplatin irradiation ) . The investigator aim find best therapeutic regimen low adverse reaction cervical cancer adverse pathological prognostic factor . To guide clinical treatment option .</brief_summary>
	<brief_title>Comparison Post-surgery Adjuvant Therapy Cervical Carcinoma</brief_title>
	<detailed_description>After radical surgery , patient stage IB1 IIA2 cervical cancer one follow pathological factor recruit : lymph node metastasis ( LNM ) , positive parametrium margin ( PPM ) , lymphatic vascular space involvement ( LVSI ) , deep invasion cervical stromal ( DIS ) . Eligible patient randomize three group . Group A underwent 50 GY RT alone . Group B receive concurrent weekly cisplatin RT . Group C receive paclitaxel bolus cisplatin every three week two cycle RT , follow two cycle . We recruit 800 patient till November 2014 .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients newly histologically confirm cervical carcinoma Original clinical stage must Ib~IIa （FIGO） Age 1865 With presence four factor radical surgery : ( 1 ) positive lymph node , ( 2 ) positive parametria , positive surgical margin , ( 3 ) positive lymphatic vascular space , ( 4 ) outer onethird invasion cervical stroma More 3 month survival expect Patients must give sign informed consent The presence uncontrolled lifethreatening illness Receiving way anticancer therapy Residual tumor remove surgery Investigator consider patient ca n't finish whole study With normal liver function test ( ALT、AST &gt; 2.5×ULN ) With normal renal function test ( Creatinine &gt; 1.5×ULN ) WBC &lt; 4,000/mm3 PLT &lt; 100,000/mm3 Receive external pelvic irradiation surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>Concurrent chemoradiation</keyword>
	<keyword>Randomized control clinical trial</keyword>
</DOC>